Back
G&T employee with Apprentice
Building future skills at Broadgate
Find out more
Back
Soldiers marching
Why the built environment provides a great career path for military leavers
Discover more
Ellipta

Ellipta Phase 3

GSK made a £75m investment in manufacturing capacity for the Ellipta inhaler system as a second manufacturing site in the USA following Phase 2 of the programme.

The project included the conversion of an onsite catering facility into manufacturing space, the refurbishment of laboratory space and filling suites, together with the delivery of assembly, packing and filling lines as well as laboratory equipment.

G&T provided project controls support involving the creation and maintenance of the master schedule, estimate development, funding application support, cost management, change and risk management as well as the preparation of monthly reports.

Client

GlaxoSmithKline (GSK)

Location

Zebulon, USA

View all projects on map

Next Project

Ellipta Phase 2

View Project
Copy the URL below and share: